SHEN Kaini, LI Jian. How can Clinicians Do A Good Job in RCT Research[J]. Medical Journal of Peking Union Medical College Hospital, 2023, 14(3): 617-620. DOI: 10.12290/xhyxzz.2022-0240
Citation: SHEN Kaini, LI Jian. How can Clinicians Do A Good Job in RCT Research[J]. Medical Journal of Peking Union Medical College Hospital, 2023, 14(3): 617-620. DOI: 10.12290/xhyxzz.2022-0240

How can Clinicians Do A Good Job in RCT Research

Funds: 

Fundamental Research Funds for the Central Universities 3332021002

More Information
  • Corresponding author:

    LI Jian, E-mail: lijian@pumch.cn

  • Received Date: April 28, 2022
  • Accepted Date: July 24, 2022
  • Available Online: August 01, 2022
  • Issue Publish Date: May 29, 2023
  • Randomized controlled trial(RCT) provides the most valid means of establishing the efficacy of clinical therapeutics. A good RCT should be based on topics with clinical significance and scientific value, and focus on the establishment of intervention and control, the method of randomization and the selection of primary endpoints. During the implementation process, details such as ethics application, research registration, data collection and regular review of the research are of great value to ensure the scientific validity of the trials and the credibility of the results.
  • [1]
    Shen KN, Fu WJ, Wu Y, et al. Doxycycline Combined With Bortezomib-Cyclophosphamide-Dexamethasone Chemotherapy for Newly Diagnosed Cardiac Light-Chain Amyloi-dosis: A Multicenter Randomized Controlled Trial[J]. Circulation, 2022, 145: 8-17. DOI: 10.1161/CIRCULATIONAHA.121.055953
    [2]
    Schulz KF, Altman DG, Moher D, et al. CONSORT 2010 statement: updated guidelines for reporting parallel group randomized trials[J]. Ann Intern Med, 2010, 152: 726-732. DOI: 10.7326/0003-4819-152-11-201006010-00232
    [3]
    Chan AW, Tetzlaff JM, Altman DG, et al. SPIRIT 2013 statement: defining standard protocol items for clinical trials[J]. Ann Intern Med, 2013, 158: 200-207. DOI: 10.7326/0003-4819-158-3-201302050-00583
    [4]
    Boutron I, Estellat C, Guittet L, et al. Methods of blinding in reports of randomized controlled trials assessing pharmacologic treatments: a systematic review[J]. PLoS Med, 2006, 3: e425. DOI: 10.1371/journal.pmed.0030425
    [5]
    Kahan BC, Morris TP. Reporting and analysis of trials using stratified randomisation in leading medical journals: review and reanalysis[J]. BMJ, 2012, 345: e5840. DOI: 10.1136/bmj.e5840
    [6]
    Glynne-Jones R, Glynne-Jones S. The concept and use of the neoadjuvant rectal score as a composite endpoint in rectal cancer[J]. Lancet Oncol, 2021, 22: e314-e326. DOI: 10.1016/S1470-2045(21)00053-X
  • Related Articles

    [1]ZHANG Shan, LIU Jie. Interpretation of NCCN Clinical Practice Guidelines for Primary Cutaneous Lymphomas (Version 1.2024) Based on the Current Diagnosis and Treatment Status of China[J]. Medical Journal of Peking Union Medical College Hospital, 2024, 15(5): 1029-1037. DOI: 10.12290/xhyxzz.2024-0605
    [2]LUO Fuchao, ZHANG Junhua, CHENG Peng, WU Jing, ZHONG Bin, LYU Bing, HUANG Guogang, LIU Yang, ZHANG Zexue, WEI Xiaohong. Clinical Application of Ultrasound-guided RISS Plane Block for Postoperative Analgesia After Minimally Invasive McKeown Esophagectomy: A Prospective Randomized Controlled Study[J]. Medical Journal of Peking Union Medical College Hospital, 2024, 15(3): 624-631. DOI: 10.12290/xhyxzz.2023-0358
    [3]ZHU He, WEN Bei, XU Li, HUANG Yuguang. Mechanism of Wnt5a on Keratinocyte Regulating MMP9 for CRPS-Ⅰ Peripheral Sensitization[J]. Medical Journal of Peking Union Medical College Hospital, 2024, 15(2): 335-343. DOI: 10.12290/xhyxzz.2023-0551
    [4]ZHANG Lu, LI Jian. Castleman Disease in China: State-of-the-art Technology Before the Era of IL-6 Targeted Therapy[J]. Medical Journal of Peking Union Medical College Hospital, 2023, 14(5): 911-914. DOI: 10.12290/xhyxzz.2023-0227
    [5]LIU Yuan, ZHAO Lin. Update and Interpretation of 2022 National Comprehensive Cancer Network Clinical Practice Guidelines for Gastric Cancer[J]. Medical Journal of Peking Union Medical College Hospital, 2022, 13(6): 999-1004. DOI: 10.12290/xhyxzz.2022-0271
    [6]ZHANG Shan, LIU Zhaorui, LIU Jie. Relationship Between SerpinB9 and Tumors and Research Progress of SerpinB9 in Skin Tumors[J]. Medical Journal of Peking Union Medical College Hospital, 2022, 13(5): 852-857. DOI: 10.12290/xhyxzz.2021-0805
    [7]Qi JIN, Qin LUO, Zhi-hui ZHAO, Zhi-hong LIU. MicroRNA-21 in the Pathogenesis of Pulmonary Hypertension[J]. Medical Journal of Peking Union Medical College Hospital, 2020, 11(4): 430-438. DOI: 10.3969/j.issn.1674-9081.2020.04.013
    [8]Hao GUO, Wen-da WANG, Yi CAI, Yu-shi ZHANG. Progress in Research on MicroRNA in Tuberous Sclerosis Complex Related Diseases[J]. Medical Journal of Peking Union Medical College Hospital, 2017, 8(4-5): 283-288. DOI: 10.3969/j.issn.1674-9081.2017.05.017

Catalog

    Article Metrics

    Article views (2367) PDF downloads (446) Cited by()
    Related

    /

    DownLoad:  Full-Size Img  PowerPoint
    Return
    Return
    x Close Forever Close